Phase
Condition
Fibromyalgia
Treatment
Wet cupping therapy (WCT)
Clinical Study ID
Ages 18-55 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Adult patients aged 18-55 years.
Female individuals to avoid the gender confounding factor.
Clinical diagnosis of primary fibromyalgia according to the 2016 American College ofRheumatology (ACR) updated diagnostic criteria.
Moderate pain intensity of ≥ 45 mm or higher on a visual analog scale (VAS).
No use of skeletal muscle relaxants, antidepressants, antiepileptic drugs,corticosteroids, benzodiazepines, and tramadol within a year before the screeningvisit.
Exclusion
Exclusion Criteria:
Underlying rheumatic, malignant, metabolic, hematological, or neurologicaldisorders.
Patients with bleeding disorders or receiving anticoagulants.
Previous use, within a year, or current use of skeletal muscle relaxants,antidepressants, antiepileptic drugs, corticosteroids, benzodiazepines, or tramadol
Patients with BMI ≤ 18 or ≥ 35.
Pregnant or lactating women.
Patients with severe anemia.
Study Design
Study Description
Connect with a study center
Rheumatology and Immunology out patient clinic, Internal Medicine Department, Cairo University
Cairo,
EgyptActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.